Prefer a chat interface with context about you and your work?
NIMG-05IDENTIFICATION OF IMAGING SIGNATURES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III (EGFRvIII) IN GLIOBLASTOMA
Glioblastoma (GBM) is the most common and aggressive adult brain tumor, with 14 months average survival. Epidermal growth factor receptor variant III (EGFRvIII) mutation is an important factor in driving tumor progression and defining prognosis in GBM patients, hence evidence of its presence can affect treatment decisions. The aim of …